Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| uniQure N.V.QURE · Entity 4162 | Chief Medical Officer | January 27, 2017 | February 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
uniQure N.V.
Report date January 27, 2017 · Filed February 21, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.37 · Expires 2027-01-27 | Direct | 43,000 |
Reported balance
After 2017-01-27 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2017-01-27 · Grant · Acquired 43,000 · Balance 43,000 F4: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F1: The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested. |
| Preformance Share UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 43,500 |
Reported balance
After 2017-01-27 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2017-01-27 · Grant · Acquired 43,500 · Balance 43,500 F4: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F2: Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. F3: Expiration date is not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested.
F2: Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020.
F3: Expiration date is not applicable.
F4: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2017 Filed Jan 31, 2017 15:20 UTC | uniQure N.V. QURE · Entity 4162 | GrantPreformance Share Unit · Derivative | 43,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-003712 · doc1.xml · derivative · entry 2 Meyer Christian · CIK 0001693826 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,250 Underlying: Ordinary Shares · 43,250 shares Expires not disclosed F2 · derivative.exercise_date: Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. F3 · derivative.expiration_date: Expiration date is not applicable. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 15:20 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 43,250 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001140361-17-003712 · doc1.xml · derivative · entry 1 Meyer Christian · CIK 0001693826 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,250 Underlying: Ordinary Shares · 43,250 shares Expires 2027-01-27 F1 · derivative.exercise_date: The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested. Read SEC document |
| January 27, 2017 Filed Feb 21, 2017 17:07 UTC Amendment | uniQure N.V. QURE · Entity 4162 | GrantPreformance Share Unit · Derivative | 43,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008384 · doc1.xml · derivative · entry 2 Meyer Christian · CIK 0001693826 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Ordinary Shares · 43,500 shares Expires not disclosed F4 · shares: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F2 · derivative.exercise_date: Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. F3 · derivative.expiration_date: Expiration date is not applicable. F4 · derivative.underlying_shares: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F4 · balance_after: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. Read SEC document |
| January 27, 2017 Filed Feb 21, 2017 17:07 UTC Amendment | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 43,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001140361-17-008384 · doc1.xml · derivative · entry 1 Meyer Christian · CIK 0001693826 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Ordinary Shares · 43,000 shares Expires 2027-01-27 F4 · shares: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F1 · derivative.exercise_date: The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested. F4 · derivative.underlying_shares: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. F4 · balance_after: Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.